We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
EOLS

Price
9.28
Stock movement up
+0.20 (2.70%)
Company name
Evolus Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
480.29M
Ent value
618.97M
Price/Sales
1.93
Price/Book
81.54
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
52.29
PEG
-
EPS growth
-10.81%
1 year return
-49.49%
3 year return
-8.87%
5 year return
14.82%
10 year return
-
Last updated: 2025-09-12

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

EOLS does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.93
Price to Book81.54
EV to Sales2.49

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count64.69M
EPS (TTM)-0.88
FCF per share (TTM)-0.40

Income statement

Loading...
Income statement data
Revenue (TTM)248.33M
Gross profit (TTM)169.48M
Operating income (TTM)-34.00M
Net income (TTM)-55.46M
EPS (TTM)-0.88
EPS (1y forward)0.15

Margins

Loading...
Margins data
Gross margin (TTM)68.25%
Operating margin (TTM)-13.69%
Profit margin (TTM)-22.33%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash85.03M
Net receivables44.64M
Total current assets150.36M
Goodwill21.21M
Intangible assets46.59M
Property, plant and equipment0.00
Total assets229.61M
Accounts payable13.84M
Short/Current long term debt8.67M
Total current liabilities60.81M
Total liabilities223.72M
Shareholder's equity5.89M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-21.99M
Capital expenditures (TTM)3.43M
Free cash flow (TTM)-25.42M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-941.60%
Return on Assets-24.15%
Return on Invested Capital-740.36%
Cash Return on Invested Capital-339.38%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open7.22
Daily high7.50
Daily low7.17
Daily Volume839K
All-time high38.49
1y analyst estimate19.00
Beta1.12
EPS (TTM)-0.88
Dividend per share-
Ex-div date-
Next earnings date11 Nov 2025

Downside potential

Loading...
Downside potential data
EOLSS&P500
Current price drop from All-time high-80.71%-1.46%
Highest price drop-92.41%-56.47%
Date of highest drop29 Oct 20209 Mar 2009
Avg drop from high-67.94%-10.99%
Avg time to new high95 days12 days
Max time to new high1813 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
EOLS (Evolus Inc) company logo
Marketcap
480.29M
Marketcap category
Small-cap
Description
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Employees
394
Investor relations
-
SEC filings
CEO
David Moatazedi
Country
USA
City
Newport Beach
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...